Exacerbation of autoantibody-mediated thrombocytopenic purpura by infection with mouse viruses

Blood

Volumn 104, Issue 7, 2004, Pages 2102-2106

  Musaji, Andrei ^a   Cormont, Françoise ^a   Thirion, Gaëtan ^a   Cambiaso, César L ^a   Coutelier, Jean Paul ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CLODRONIC ACID; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; IMMUNOGLOBULIN G; LIPOSOME; THROMBOCYTE ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LACTIC DEHYDROGENASE TOGAVIRUS; MOLECULAR MIMICRY; MOUSE; MURINE HEPATITIS CORONAVIRUS; NONHUMAN; PATHOGENESIS; PETECHIA; PHAGOCYTOSIS; PRIORITY JOURNAL; SUPERINFECTION; THROMBOCYTE ANOMALY; VIRUS INFECTION;

EID: 4644240423     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-01-0310     Document Type: Article

References (17)

1. Rand ML, Wright JF. Virus-associated idiopathic thrombocytopenic purpura. Transfus Sci. 1998;19:253-259.
2. Nugent DJ. Childhood immune thrombocytopenic purpura. Blood Rev. 2002;16:27-29.
3. Semple JW. Immune pathophysiology of autoimmune thrombocytopenic purpura. Blood Rev. 2002;16:9-12.
4. Nieswandt B, Bergmeier W, Rackebrandt K, Gessner JE, Zirngibl H. Identification of critical antigen-specific mechanisms in the development of immune thrombocytopenic purpura in mice. Blood. 2000;96:2520-2527.
5. Oyaizu N, Yasumizu R, Miyama-Inaba M, et al. (NZW x BXSB)F1 mouse. A new animal model of idiopathic thrombocytopenia purpura. J Exp Med. 1988;167:2017-2022.
6. Musaji M, Vanhoorelbeke K, Deckmyn H, Coutelier J-P. A new model of transient strain-dependent autoimmune thrombocytopenia in mice immunized with rat platelets. Exp Hematol. 2004;32:87-94.
7. Huang S, Hendriks W. Althage A, et al. Immune response in mice that lack the interferon-γ receptor. Science. 1993;259:1742-1745.
8. Cambiaso CL, Van Vooren JP, Farber CM. Immunological detection of mycobacterial antigens in infected fluids, cells and tissues by latex agglutination. J Immunol Meth. 1990;129:9-14.
9. Nieswandt B, Echtenacher B, Wachs F-P, et al. Acute systemic reaction and lung alterations induced by an antiplatelet integrin gpIIb/IIIa antibody in mice. Blood. 1999;94:684-693.
10. Van Rooijen N. The liposome-mediated macrophage "suicide" technique. J Immunol Methods. 1989;124:1-6.
11. Alves-Rosa F, Stanganelli C, Cabrera J, van Rooijen N, Palermo MS, Isturiz MA. Treatment with liposome-encapsulated clodronate as a new strategic approach in the management of immune thrombocytopenic purpura in a mouse model. Blood. 2000;96:2834-2840.
12. Jordan MB, van Rooijen N, Izui S, Kappler J, Marrack P. Liposomal clodronate as a novel agent for treating autoimmune hemolytic anemia in a mouse model. Blood. 2003;101:594-601.
13. Pettier Y, Pierard I, Barclay A, Masson PL, Coutelier J-P. The mode of action of treatment by IgG of haemolytic anaemia induced by an anti-erythrocyte monoclonal antibody. Clin Exp Immunol. 1996;106:103-107.
14. Coutelier J-P, Van Snick J. Isotypically restricted activation of B lymphocytes by lactic dehydrogenasevirus. Eur J Immunol. 1985;15:250-255.
15. Meite M, Léonard S, El Azami El Idrissi M, Izui S, Masson PL, Coutelier J-P. Exacerbation of autoantibody-mediated hemolytic anemia by viral infection. J Virol. 2000;74:6045-6049.
16. Markine-Goriaynoff D, Hulhoven X, Cambiaso CL, et al. Natural killer cell activation after infection with lactate dehydrogenase-elevating virus. J Gen Virol. 2002;83:2709-2716.
17. Schijns VE, Wierda CM, Van Hoeij M, Horzinek MC. Exacerbated viral hepatitis in IFN-gamma receptor-deficient mice is not suppressed by IL-12. J Immunol. 1996;157:815-821.